LENZ Therapeutics, Inc. and Corxel Pharmaceuticals announced topline data from a Phase 3 clinical trial of LNZ100 for presbyopia in China on October 27, 2024.
AI Assistant
LENZ THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.